Related references
Note: Only part of the references are listed.Proteomics for early detection of colorectal cancer: recent updates
Abdo Alnabulsi et al.
EXPERT REVIEW OF PROTEOMICS (2018)
Revisiting biomarker discovery by plasma proteomics
Philipp E. Geyer et al.
MOLECULAR SYSTEMS BIOLOGY (2017)
A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline
Xiaohui Liu et al.
BRITISH JOURNAL OF CANCER (2017)
A targeted proteomic strategy for the measurement of oral cancer candidate biomarkers in human saliva
Rebeca Kawahara et al.
PROTEOMICS (2016)
Blood Lipid Concentrations and Colorectal Adenomas: A Systematic Review and Meta-Analysis of Colonoscopy Studies in Asia, 2000-2014
Michael N. Passarelli et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2016)
Human SRMAtlas: A Resource of Targeted Assays to Quantify the Complete Human Proteome
Ulrike Kusebauch et al.
CELL (2016)
Apolipoproteins, lipids and risk of cancer
Signe Borgquist et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
The Perseus computational platform for comprehensive analysis of (prote)omics data
Stefka Tyanova et al.
NATURE METHODS (2016)
Development of a novel multiplex beads-based assay for autoantibody detection for colorectal cancer diagnosis
Roi Villar-Vazquez et al.
PROTEOMICS (2016)
Parallel reaction monitoring using quadrupole-Orbitrap mass spectrometer: Principle and applications
Adele Bourmaud et al.
PROTEOMICS (2016)
Prediction of colorectal cancer diagnosis based oncirculating plasma proteins
Silvia Surinova et al.
EMBO MOLECULAR MEDICINE (2015)
Colorectal cancer screening: a global overview of existing programmes
Eline H. Schreuders et al.
GUT (2015)
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies
Eugenia R. Zanella et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Proteomics in colorectal cancer translational research: Biomarker discovery for clinical applications
Meike de Wit et al.
CLINICAL BIOCHEMISTRY (2013)
Identification of potential bladder cancer markers in urine by abundant-protein depletion coupled with quantitative proteomics
Chien-Lun Chen et al.
JOURNAL OF PROTEOMICS (2013)
The CRAPome: a contaminant repository for affinity purification-mass spectrometry data
Dattatreya Mellacheruvu et al.
NATURE METHODS (2013)
Colorectal cancer screening-optimizing current strategies and new directions
Ernst J. Kuipers et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Comparative proteomic profiles indicating genetic factors may involve in hepatocellular carcinoma familial aggregation
Da-Ni Zhong et al.
CANCER SCIENCE (2012)
Comparative profiling of plasma proteome from breast cancer patients reveals thrombospondin-1 and BRWD3 as serological biomarkers
Eui Jin Suh et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2012)
A Multiplexed Serum Biomarker Immunoassay Panel Discriminates Clinical Lung Cancer Patients from High-Risk Individuals Found to be Cancer-Free by CT Screening
William L. Bigbee et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Plasma biomarker discovery and validation for colorectal cancer by quantitative shotgun mass spectrometry and protein microarray
Yusuke Murakoshi et al.
CANCER SCIENCE (2011)
On the Development of Plasma Protein Biomarkers
Silvia Surinova et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Emerging molecular biomarkers-blood-based strategies to detect and monitor cancer
Samir M. Hanash et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
The Bottleneck in the Cancer Biomarker Pipeline and Protein Quantification through Mass Spectrometry-Based Approaches: Current Strategies for Candidate Verification
Shalini Makawita et al.
CLINICAL CHEMISTRY (2010)
Role of systemic inflammatory response in predicting survival in patients with primary operable cancer
Campbell S. D. Roxburgh et al.
FUTURE ONCOLOGY (2010)
Depletion of Abundant Plasma Proteins and Limitations of Plasma Proteomics
Chengjian Tu et al.
JOURNAL OF PROTEOME RESEARCH (2010)
GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
Eran Eden et al.
BMC BIOINFORMATICS (2009)
Identification of Tumor-associated Autoantigens for the Diagnosis of Colorectal Cancer in Serum Using High Density Protein Microarrays
Ingrid Babel et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Thrombospondins in cancer
S. Kazerounian et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
Juergen Cox et al.
NATURE BIOTECHNOLOGY (2008)
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer
Gershon Y. Locker et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Expression of thrombospondin-1 in resected colorectal liver metastases predicts poor prognosis
CD Sutton et al.
CLINICAL CANCER RESEARCH (2005)
The PANTHER database of protein families, subfamilies, functions and pathways
HY Mi et al.
NUCLEIC ACIDS RESEARCH (2005)
Extracellular matrix protein 1 (ECM1) is over-expressed in malignant epithelial tumors
LP Wang et al.
CANCER LETTERS (2003)
IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai
NM Probst-Hensch et al.
BRITISH JOURNAL OF CANCER (2001)
Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas
O Straume et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer
AG Renehan et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
